Attached files
file | filename |
---|---|
10-Q - U.S. Stem Cell, Inc. | d26681.htm |
EX-31.1 - U.S. Stem Cell, Inc. | d26681_ex31-1.htm |
EX-31.2 - U.S. Stem Cell, Inc. | d26681_ex31-2.htm |
EX-32.1 - U.S. Stem Cell, Inc. | d26681_ex32-1.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly
Report of Bioheart, Inc. (the Company) on Form 10-Q for the quarter ended March 31, 2010 as filed with the Securities and Exchange
Commission on the date hereof (the Report), the undersigned officer of the Company hereby certifies, pursuant to 18 U.S.C. section 906 of
the Sarbanes-Oxley Act of 2002, to such officers knowledge that:
(i) the Quarterly Report on Form 10-Q of the Company for
the quarterly period ended March 31, 2010 (the Report) fully complies with the requirements of Section 13(a) or Section 15(d), as
applicable, of the Securities Exchange Act of 1934, as amended (subject to the Companys position prevailing in regard to the remaining unresolved
SEC comment, as more fully described in the Report); and
(ii) the information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations of the Company.
A signed original of this written
statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.
May 14,
2010 |
/s/ Peggy A. Farley |
|||||
Name:
Peggy A. Farley |
||||||
Title: Principal Financial and Accounting Officer |